StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) KPIs and segments

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

KPIs & segments

Operating metrics and segments that drive Amneal Pharmaceuticals's business

Amneal Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Affordable Medicines($M)11
490423437461433415439427427391363391
Subtotal dosage forms($M)
482418432413
United States($M)
437461433415439427427391
Oral solid($M)
175171178179
Other dosage forms($M)
81.646.668.256.4
Transdermal($M)
67.074.040.743.1
Auto-Injector($M)
62.241.966.648.2
Injectable($M)
56.849.934.634.8
Biosimilar($M)
29.122.325.228.5
Oral liquid($M)
10.412.117.923.5
International($M)
7.615.321.901.23
International and other($M)
4.511.431.720.450.87
AvKARE($M)4
157166211199163172170159170163149132
Distribution($M)
86.989.199.7105
Government label($M)
50.259.945.450.1
Institutional($M)
12.19.8210.111.0
Other($M)
7.747.107.836.37
Specialty($M)5
14913316712512810812111610410510497.3
Subtotal therapeutic classes($M)
149133128108
Central nervous system($M)
95.383.483.467.6
Hormonal/Allergy($M)
42.135.935.434.2
Other therapeutic classes($M)
11.914.08.706.49
License agreement($M)
00.50
Affordable Medicines($M)
12312182.085.610211191.988.3101-11.446.987.4
Specialty($M)
54.950.19.5735.515.032.426.929.218.6
AvKARE($M)
9.3422.425.527.018.112.97.4613.111.011.39.1211.9
Affordable Medicines($M)
207191151180181172178178166151141155
Specialty($M)
10190.251.472.255.263.357.960.451.8
AvKARE($M)
26.239.142.742.333.228.623.528.325.626.323.226.2

14 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-06.

See a number that looks wrong?